Le Lézard
Classified in: Business
Subject: INO

Thinking about buying stock in Dyne Therapeutics, Applied Therapeutics, ON Semiconductor, Mereo BioPharma, or Neximmune?


NEW YORK, Jan. 3, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DYN, APLT, ON, MREO, and NEXI.

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  1. DYN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=DYN&prnumber=202401032
  2. APLT: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=APLT&prnumber=202401032
  3. ON: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ON&prnumber=202401032
  4. MREO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=MREO&prnumber=202401032
  5. NEXI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=NEXI&prnumber=202401032

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

SOURCE InvestorsObserver


These press releases may also interest you

at 16:50
Bain Capital Specialty Finance, Inc. Announces March 31, 2024 Financial Results and Declares Second Quarter 2024 Dividend of $0.42 per Share
Bain Capital Specialty Finance, Inc. today announced financial results for the first quarter ended March 31, 2024, and that its Board of Directors (the "Board") has declared a dividend of $0.42 per share for the second quarter of 2024 and an...

at 16:50
Freehold Royalties Announces First Quarter Results
Freehold Royalties Ltd. (Freehold or the Company) announces first quarter results for the period ended March 31, 2024. President's Message $74 million in revenue;$54 million in funds from operations ($0.36/share) (1);$41 million in dividends paid...

at 16:49
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Altimmune, Inc. ("Altimmune" or the "Company") and reminds investors of the July 5, 2024 deadline to seek the role of lead plaintiff in a federal...

at 16:45
ThreeD Capital Inc. Announces Unaudited April 30, 2024 Net Asset Value Per Share - $0.75
ThreeD Capital Inc. ("ThreeD" or the "Company") a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that at April 30, 2024, its unaudited net...

at 16:40
Masonite International Corporation Reports First Quarter Results
Masonite International Corporation ("Masonite" or the "Company") today announced results for the three months ended March 31, 2024. ($ in millions, except per share amounts) 1Q24   1Q23   % Change Net sales...

at 16:40
Rocket Lab Announces First Quarter 2024 Financial Results Reflecting Year-on-Year Revenue Growth of 69%, Sequential Quarterly Growth of 55%, and Continued Growth in Q2 2024
Rocket Lab USA, Inc. ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter ended March 31, 2024. Rocket Lab founder and CEO Peter Beck said: "Rocket Lab...

More news about Business...


News published on and distributed by: